Nurcan Gumus

4PUBLICATIONS
14CO-AUTHORS
NanometrologyMolecular targetsPolymers and plastics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 25, 2025
Targeting leukemic stem cells: enhanced eradication via tivantinib (ARQ197) and asciminib (ABL001) with molecular docking-guided screening of therapeutic derivatives.

İlknur Karatekin Arik, Nurcan Gümüş, İlayda Alcitepe

|Feb 26, 2025
Pentablock thermoresponsive hydrogels for chemotherapeutic delivery in a pancreatic cancer model.

Amr Elsherbeny, Hulya Bayraktutan, Nurcan Gumus

|Nov 29, 2021
STAT5 inhibitor Pimozide as a probable therapeutic option in overcoming Ponatinib resistance in K562 leukemic cells.

Nurcan Gumus, Cumhur Gunduz, Burcin Tezcanli Kaymaz

Pageof 1